Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Healthcare | 2.87% |
| 3 | Financials | 2.57% |
| 4 | Consumer Discretionary | 2.23% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4976
PUT
Azenta
AZTA
$1.46B
| $2.52M | ﹤0.01% |
43,300
+25,100
| +138% | +$1.28M |
|
4977
CALL
MSC Industrial Direct
MSM
$6.91B
| $2.52M | ﹤0.01% |
30,800
+22,900
| +290% | +$1.87M |
|
4978
iShares MSCI USA Size Factor ETF
SIZE
$447M
| $2.51M | ﹤0.01% |
22,112
+17,370
| +366% | +$1.97M |
|
4979
PUT
BioCryst Pharmaceuticals
BCRX
$2.49B
| $2.51M | ﹤0.01% |
219,000
-20,800
| -9% | -$259K |
|
4980
IDT Corp
IDT
$1.66B
| $2.51M | ﹤0.01% |
89,245
+58,180
| +187% | +$1.56M |
|
|
BERY
4981
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $2.51M | ﹤0.01% |
45,194
+14,157
| +46% | +$694K |
|
|
RCM
4982
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.51M | ﹤0.01% |
229,000
+199,500
| +676% | +$2.53M |
|
4983
CALL
FS KKR Capital
FSK
$3.42B
| $2.5M | ﹤0.01% |
143,100
+57,600
| +67% | +$1.07M |
|
4984
PUT
Barclays
BCS
$94.7B
| $2.5M | ﹤0.01% |
321,000
+155,900
| +94% | +$1.14M |
|
|
LKFT
4985
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $2.5M | ﹤0.01% |
56,400
+38,400
| +213% | +$1.62M |
|
4986
GATX Corp
GATX
$6.38B
| $2.5M | ﹤0.01% |
23,530
+14,438
| +159% | +$1.5M |
|
|
RVNC
4987
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.5M | ﹤0.01% |
135,500
-310,600
| -70% | -$7.1M |
|
|
AGEN
4988
Agenus
AGEN
$329M
| $2.5M | ﹤0.01% |
53,077
+29,893
| +129% | +$1.52M |
|
4989
CALL
ProShares UltraShort Dow 30
DXD
$42.7M
| $2.5M | ﹤0.01% |
57,860
-11,880
| -17% | -$542K |
|
|
CSGS
4990
DELISTED
CSG Systems International
CSGS
| $2.5M | ﹤0.01% |
+43,701
| New | +$2.57M |
|
4991
CALL
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.3B
| $2.5M | ﹤0.01% |
32,800
+13,900
| +74% | +$1.22M |
|
4992
Alpha and Omega Semiconductor
AOSL
$931M
| $2.5M | ﹤0.01% |
87,423
-6,332
| -7% | -$205K |
|
4993
Kura Sushi USA
KRUS
$643M
| $2.49M | ﹤0.01% |
+52,259
| New | +$3.47M |
|
4994
PUT
BorgWarner
BWA
$14B
| $2.49M | ﹤0.01% |
70,318
-16,472
| -19% | -$560K |
|
|
CEQP
4995
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.49M | ﹤0.01% |
95,000
+22,700
| +31% | +$655K |
|
4996
PUT
Reinsurance Group of America
RGA
$16.3B
| $2.49M | ﹤0.01% |
17,500
+13,400
| +327% | +$1.87M |
|
4997
CALL
Bio-Techne
TECH
$11.3B
| $2.49M | ﹤0.01% |
30,000
-12,000
| -29% | -$953K |
|
4998
Central Pacific Financial
CPF
$996M
| $2.48M | ﹤0.01% |
+122,524
| New | +$2.52M |
|
|
DCH
4999
PUT
Dauch Corp
DCH
$1.6B
| $2.48M | ﹤0.01% |
317,700
-97,100
| -23% | -$870K |
|
5000
The Ensign Group
ENSG
$10.6B
| $2.48M | ﹤0.01% |
26,259
-126,259
| -83% | -$11.5M |
|
Similar funds
Ken Griffin's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.
- Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
- Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
- Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.